Banner image placeholder
Banner image

Structure-based screening and a conformational biosensor identify a GPR183 inverse agonist and an activation switch


Journal article


L. Andersson, Michele Roggia, K. Wangriatisak, Rhiannon Skye Kozel, Holly R. Brittain, Sonia Youhanna, M. Gil, Mathias Haag, V. Lauschke, Karine Chemin, Sandro Cosconati, P. Kozielewicz
Nature Communications, 2026

Semantic Scholar DOI
Cite

Cite

APA   Click to copy
Andersson, L., Roggia, M., Wangriatisak, K., Kozel, R. S., Brittain, H. R., Youhanna, S., … Kozielewicz, P. (2026). Structure-based screening and a conformational biosensor identify a GPR183 inverse agonist and an activation switch. Nature Communications.


Chicago/Turabian   Click to copy
Andersson, L., Michele Roggia, K. Wangriatisak, Rhiannon Skye Kozel, Holly R. Brittain, Sonia Youhanna, M. Gil, et al. “Structure-Based Screening and a Conformational Biosensor Identify a GPR183 Inverse Agonist and an Activation Switch.” Nature Communications (2026).


MLA   Click to copy
Andersson, L., et al. “Structure-Based Screening and a Conformational Biosensor Identify a GPR183 Inverse Agonist and an Activation Switch.” Nature Communications, 2026.


BibTeX   Click to copy

@article{l2026a,
  title = {Structure-based screening and a conformational biosensor identify a GPR183 inverse agonist and an activation switch},
  year = {2026},
  journal = {Nature Communications},
  author = {Andersson, L. and Roggia, Michele and Wangriatisak, K. and Kozel, Rhiannon Skye and Brittain, Holly R. and Youhanna, Sonia and Gil, M. and Haag, Mathias and Lauschke, V. and Chemin, Karine and Cosconati, Sandro and Kozielewicz, P.}
}


Share


Translate to